markapplication

423 results found.

Top Stocks matching your search for "mark application"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 27, 2023

Super excited for tomorrow's ER Guidance Call ... See more

Jan, 21, 2023

They're FDA approved, have the best in class t... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 14, 2023

$AVXL I am extremely bullish on the data .. the F... See more

Feb, 5, 2023

Guys from the fda that really know their stuff.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
KALA

Kala Pharmaceuticals Inc

-9.01%

$16.65 - $15.15

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 19, 2023

Going to be fda approved and going to new highs.

Mar, 9, 2023

Absolutely revolutionary FDA $1.00 moving up.

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 27, 2023

Super excited for tomorrow's ER Guidance Call for our first ever FDA approved commercialized product, Briumvi!

Jan, 21, 2023

They're FDA approved, have the best in class treatment, and is more affordable than the others.

Dec, 30, 2022

$JAZZ $TGTX FDA APPROVED ON 12/28/22 . BUY/HOLD/ACCUMULATE

Dec, 30, 2022

$KALA up 46%, rallies 3rd day in a row following FDA acceptance of IND application of KPI-012 & $TGTX is up 13% continued momentum following MS drug approvals.

Dec, 30, 2022

i don’t know any retail that would buy 545k shares… this one actually has news like real lets make money news unlike all these other application garbage pr from shitty bios

Dec, 30, 2022

Our best in class drug is FDA APPROVED.

Dec, 30, 2022

$TGTX $KALA $HOTH $NUWE TGTX on fire 🔥 and solid from fundamentals perspective after yesterday FDA approval of Multiple Sclerosis Billion dollar drug revenue potential.

Dec, 30, 2022

Great FDA approval news in a growing MS market with a need.

Dec, 30, 2022

$TGTX , absolutely amazing….Scumbag’s Bank of America analyst rated TG today as underperform $6….total joke….I guess the analyst is waiting for FDA approval…LOL ….stick to loans and mortgages….very bullish TG community Longs….

Dec, 29, 2022

$TGTX FDA approval for Billion dollar MS drug — great things in store 2023 $DRMA just officially dropped offering, makes me feel company has something good up it’s sleeve.

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 14, 2023

$AVXL I am extremely bullish on the data .. the FDA can ask any sorts of questions

Feb, 5, 2023

Guys from the fda that really know their stuff.

Jan, 24, 2023

He said Anavex could do that also and all of that makes Anavex pleased how easy the FDA wants to make Accelerated approval here.

Jan, 23, 2023

That means Rett NDA sections common with the Alzheimer's NDA sections will be completed simultaneously, which is good for the Alzheimers NDA. 3.

Jan, 23, 2023

“Statistically significant improvements in lung function, symptoms and quality of life 36% reduction in rate of exacerbations over 24 weeks Well tolerated safety profile over 48 weeks NDA submission planned for 1H 2023” Oh, 48 weeks! !

Jan, 15, 2023

They would be able to provide medical writing, copy editing, and creative support (the latter for making figures) to the authors to expedite manuscript development and submission.

Jan, 13, 2023

The FDA and global agencies find great comfort in NDAs accompanied by a peer review.

Jan, 6, 2023

look into Adamis Pharma, no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!

Jan, 6, 2023

With all the scrutiny with on the FDA they will definitely be forced to approve Anavex which is the safest, cheapest on Healthcare and the patients, and most convenient drug.

KALA

Kala Pharmaceuticals Inc

-9.01%

$16.65 - $15.15

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 19, 2023

Going to be fda approved and going to new highs.

Mar, 9, 2023

Absolutely revolutionary FDA $1.00 moving up.

Jan, 11, 2023

FDA pre approvel, best TRENDING stock of the moment!

Jan, 9, 2023

$KALA is the one up 500% on Phase 2 results where FDA approval of any possible kind is many years away and where the company is burning through $80 million per year for zero results.

Dec, 31, 2022

$KALA Great calls in our discord all week and also running on great FDA news. https://youtu.be/7CvA--rrXpk

Dec, 30, 2022

$KALA More to come: MW Kala Pharmaceuticals stock up 750% in 3 days after upbeat FDA news on PCED treatment

Dec, 28, 2022

$KALA FDA approved!

Dec, 28, 2022

the FDA gives a thumbs up or thumbs down and you keep moving ahead

Dec, 28, 2022

$EDSA love love love this stock — another billion dollar medication, for covid, FDA expected soon.

Nov, 29, 2022

Great start to the week $NAOV went operation moon on that headline from the FDA, $DBGI continuation play with a crazy move.